Berita
Peristiwa
Politik
Ekonomi
Teknologi
Otomotif
Olahraga
Gaya Hidup
Travel
More
Video
Media OutReach
Globenewswire
Advertorial
Pilihan Editor
Terpopuler
Indeks
Berita
Politik
Peristiwa
Ekonomi
Otomotif
Olahraga
Teknologi
Gaya Hidup
Travel
Video
Media OutReach
Globenewswire
Advertorial
Pilihan Editor
Terpopuler
Indeks
Berita
Peristiwa
Politik
Ekonomi
Teknologi
Otomotif
Olahraga
Gaya Hidup
Travel
More
Video
Media OutReach
Globenewswire
Advertorial
Pilihan Editor
Terpopuler
Indeks
Okta
Okta
Index
Media OutReach
Okta Appoints Stephanie Barnett as Vice President of Presales for Asia Pacific & Japan
Kamis, 22 Juni 2023 - 23:00:00 Wib
Media OutReach
Okta Introduces Okta Device Access to Help Organizations Mature their Zero Trust Strategy
Senin, 19 Juni 2023 - 23:00:00 Wib
Media OutReach
Use of MFA Nearly Doubles Since 2020, New Okta Secure Sign-In Trends Reports Finds
Selasa, 13 Juni 2023 - 23:32:30 Wib
Terpopuler
Index
1
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
Dibaca:
134
Kali
2
Coralogix Adds Macquarie Capital Venture Capital as Investor to Accelerate Expansion Across Australia and New Zealand
Dibaca:
177
Kali
3
Coventry’s LILY Funding Program Reaches $1 Billion in Life Insurance-Backed Financing
Dibaca:
129
Kali
4
Founder Group Announces Investment in Nichcom Go Sdn. Bhd., Operator of SpacePlus EV Charging Network, to Expand Market Leadership in EV Industry
Dibaca:
136
Kali
5
Grand Challenges Canada dan AVPN Meluncurkan Nexa Lighthouse untuk Mendanai Inovasi Iklim dan Kesehatan di Kawasan Asia dan Pasifik
Dibaca:
125
Kali
Terkini
Index
Binzhou Unveils "Trade-In" Housing Models to Stabilize Real Estate Market
26 Agustus 2026
Hardcore Quality Conquers Global Users: GREE Premium RACs Top the 2025 Global Sales
26 Agustus 2026
Only 49% of Singaporeans Feel Prepared for the Next Decade
26 Agustus 2026
JOYY Delivers YoY and QoQ Growth in Total Revenues as Diversified Businesses Sustain Strong Momentum
26 Agustus 2026
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
25 Agustus 2026